DNA ENCODING PHAGE ABORTIVE INFECTION PROTEIN FROM LACTOCOCCUS LACTIS, AND METHOD OF USE THEREOF

Abstract: DNA encoding phage resistance protein which aborts infection by the phage, designated as AbiE. The DNA which is contained in a Lactococcus lactis deposited as NRRL-B-21443 and described in SEQ ID NO:1, is incorporated into a bacterium to encode the AbiE and provide phage resistance. Lactococcus and other bacteria encoding the AbiE are useful in industrial fermentations wherein phage are a problem.

Description: DNA ENCODING PHAGE ABORTIVE INFECTION PROTEIN FROM LACTOCOCCUS LACTIS, AND METHOD OF USE THEREOF BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to DNA isolated in a plasmid or in a bacterium encoding a phage resistance protein (designated as AbiE) which aborts infection of the bacterium by the phage. In particular the present invention relates to methods of using the DNA to provide the phage resistance. (2) Description of Related Art Lactococcus lactis is widely used in mesophilic milk fermentations to produce cheese, buttermilk, cottage cheese and sour cream. Due to the expanding activities in these industries, there is pressure on L . lactis starter cultures to perform at industrial standards of consistency and efficiency. Phages are the leading cause of fermentation failures during the manufacture of these cultured dairy products (Jarvis A. W. , et al., Intervirology 32:2-9 (1991)). They can ruin a fermentation by inactivating the inoculated, sensitive cultures. Since identification of the causal agent in the mid-30s, the dairy industry has learned to manage with this natural phenomenon by developing various solutions such as better sanitation, process modifications and use of phage-resistant cultures (Hill, C, FEMS Microbiol. Rev. 12:87-108 (1993) ) . Extensive studies have been carried out on the innate phage resistance mechanisms of L. lactis strains (for review see Hill, C, FEMS Microbiol. Rev. 12:87-108 (1993)) . Native barriers against phages have been found and most of them are encoded on plasmids. More than 40 plasmids encoding a variety of phage resistance mechanisms have been identified (Hill, C. , FEMS Microbiol. Rev. 12:87-108 (1993)) . These anti-phage systems are currently classified in three groups based on their mode of action: blocking of phage adsorption, restriction/modification (R/M) , and abortive infection (Abi) . Amongst the natural L . lactis phage resistance mechanisms, the Abi systems are believed to be the most powerful due to their overall effects (Sing, W. D., et al., J. Dairy Sci. 73:2239-2251 (1990)) . In a classical abortive infection, the phage lytic cycle is inhibited but after adsorption, DNA injection and early phage gene expression. The end result is the typical Abi + phenotype of reduced burst size and plaque size (McLandsborough, L. A., et al., Appl. Environ. Microbiol. 61:2023-2026 (1995); Molineux, I. J., New Biol. 3:230-236 (1991); Sing, W. D. , et al., J. Dairy Sci. 73:2239-2251 (1990); Snyder, L. , Mol. Microbiol. 15:415-420 (1995)) . Generally, the host is also killed in the abortive process. This suicidal outcome traps the phages within the infected cell and limits their dissemination (Sing, W. D. , et al., J. Dairy Sci. 73:2239-2251 (1990)). Many Abi systems have been identified in other bacterial genera (for review see Molineux, I. J. , New Biol. 3:230-236 (1991); and Snyder, L. , Mol. Microbiol. 15:415-420 (1995)) . Some of these systems have been studied extensively but the molecular basis remains somewhat unclear (Snyder, L. , Mol. Microbiol. 15:415-420 (1995)) . Recent evidence are now only leading to more specific models for their action (Molineux, I. J., New Biol. 3:230-236 (1991); and Snyder, L. , Mol. Microbiol. 15:415-420 (1995)) . Likewise, Abi systems are very poorly understood in L . lactis (Sing, W. D., et al., J. Dairy Sci. 73:2239-2251 (1990)). To date, five Abi systems have been characterized to molecular level: AbiA (Hill, C, et al., Appl. Environ. Microbiol. 56:2255- 2258 (1990), AbiB (Cluzel, P. J., et al., Appl. Environ. Microbiol. 57:3547-3551 (1991), AbiC (Durmaz, E. , et al., J. Bacteriol. 174:7463-7469 (1992) , AbiD (McLandsborough, L. A., et al., Appl. Environ. Microbiol. 61:2023-2026 (1995) and AbiDl (Anba, J. , et al. , J. Bacteriol. 177:3818-3823 (1995) . These systems were isolated from different L . lactis strains. There is no homology between the Abi proteins except for AbiD and AbiDl which shared 28% identity (52% similarity) . This was the first indication on the existence of a possible family of Abi proteins in L . lactis (Anba, J. , et al., J. Bacteriol. 177:3818-3823) . The absence of homology between the other L . lactis Abi mechanisms suggests different mode of action and/or phage targets. Very limited information is available on the molecular mechanisms of L . lactis Abi systems. AbiA is believed to somehow interfere with DNA replication of small isometric phages (Hill, C. , et al., Appl. Environ. Microbiol. 57:283-288 (1991); and Moineau, S., et al. , Appl. Environ. Microbiol. 59:208-212 (1993)) . AbiC does not prevent phage DNA replication but reduces the synthesis of structural phage proteins in infected cells (Durmaz, E. , et al., J. Bacteriol. 174:7463-7469 (1992); and Moineau, S., et al., Appl. Environ. Microbiol. 59:208-212 (1993)) . Recently, Bidnenko et al . (Bidnenko, E., et al., J. Bacteriol. 177:3824-3829 (1995)) reported that AbiDl interacted with a small isometric phage operon which contained 4 open reading frames (ORFs) . It was proposed that AbiDl and the or/1 gene product interacted to prevent translation of orf3 RNA (Bidnenko, E., et al., J. Bacteriol. 177:3824-3829 (1995)) . Industrial L . lactis strains with enhanced phage resistance have been constructed by introducing natural plasmids containing Abi systems into phage- sensitive strains (Sanders, M. E., et al., Appl. Environ. Microbiol. 52:1001-1007 (1986)) . These improved strains have already been successfully employed for large scale dairy fermentations. However new phages capable of overcoming the introduced Abi defense system have emerged (Alatossava, T., et al., Appl. Environ. Microbiol. 57:1346-1353 (1991); and Moineau, S., et l., Appl. Environ. Microbiol. 59:197-202 (1993) ) . Thus, the search for novel phage resistance mechanisms is an ongoing objective for culture suppliers (Moineau, S., et al., Appl. Environ. Microbiol. 61:2193-2202 (1995)) . Lactococcal phages are classified in 12 different species based on morphology and DNA homology (Jarvis, A. W. , et al., Intervirology 32:2-9 (1991)) . Only three have been studied for genetic details because they are commonly encountered worldwide in dairy plants (Jarvis, A. W., et al., Intervirology 32:2-9 (1991)). Members of the species 936 (small isometric heads) , c2 (prolate heads) and P335 (small isometric heads) have been, by far, the most disturbing lactococcal phages (Jarvis, A. W. , et al., Intervirology 32:2-9 (1991); and Moineau, S., et al., Can. J. Microbiol. 38:875-882 (1992)) . DNA-DNA hybridization studies have revealed the absence of significant DNA homology between the three species (Jarvis, A. W. , et al., Intervirology 32:2-9 (1991)) . The current consensus is that the 936, P335 and c2 species are genetically distinct and L . lactis starter cultures should be resistant against these phages (Moineau, S., et al., Appl. Environ. Microbiol. 61:2193-2202 (1995)) . OBJECTS It is an object of the present invention to provide DNA encoding a sixth and novel abortive infection mechanism (Abi) from L . lactis which acts prior to or at the phage DNA replication and shares no homology with the previously isolated Abi from L . lactis . Further, it is an object of the present invention to provide a novel Abi system which is efficient against 936, c2 and P335 phages. Further, it is an object of the present invention to provide a method and bacteria which prevent phage inactivation of Lactococcus lactis strains. Further still, it is an object of the present invention to provide a recombinant bacteria which are economical to prepare and effective in phage inhibition. These and other objects will become increasingly apparent by reference to the following description and the drawings. BRIEF DESCRIPTION OF DRAWINGS Figure 1 is a photograph of an electrophoresis gel showing a plasmid analysis of Lactococcus lactis strains. Lanes: 1 and 5, supercoiled DNA ladder (Gibco/BRL, Grand Island, NY); 2, L . lactis SMQ-16; 3, L . lactis SMQ-20; 4, L . lactis W-l (containing plasmid pSRQ800) . Figure 2 is a circular restriction map of lactococcal plasmid pSRQ800. Site positions are indicated in kilobases. Figure 3 is a linear restriction map of plasmid pSRQ800 and subclones used to localized the abiE gene. The DNA regions represented by the horizonal lines were subcloned into pSA3. The lines are bordered with vertical bars which indicates the site of cloning. The clones were electroporated in L . lactis LM0230 and the transformants tested for resistance against φp2. For sequencing purposes, the 4.5-kb EcoRI fragment was cut in three segments and subcloned into pBS. Figure 4 is a nucleotide sequence of the 4.5- kb £coRI fragment from pSRQ800 as shown in SEQ ID NO:l. The deduced amino acid sequence of the only significant open reading frame is presented. The putative promoter and RBS are underlined. Figures 5A and 5B are electrophoresis gels showing øul36 DNA replication followed at time intervals during infection of L. lactis SMQ-86 (left side) and SMQ-88 (right side) . 1-ml samples were taken at time intervals and the total DNA isolated according to the Hill et al. procedure (Hill, C, et al. , Appl. Environ. Microbiol. 57:283-288 (1991)) . Total DNA was cut with EcoRV and a sample run on a 0.7% agarose gel. Lane M, 1-kb ladder (Gibco/BRL) ; Lane C, DNA sample prior to phage infection; Lane 0, 15, 30, 45, 65, 75 and 90 indicates time intervals (min.) . Figure 5C is a graph showing accumulation of the major capsid protein of φuL36 followed at time intervals during infection of L . lactis SMQ-86 and SMQ- 88 using an ELISA detection system described previously (Moineau, Ξ., et al., Appl. Environ. Microbiol. 59:208- 212 (1993)) . An O.D. of 0.389 ± 0.132 was obtained at time 105 with infected SMQ-88 cells. Symbols: o, SMQ-86 (pSA3) ; • SMQ-88 (pSRQ802) . Error bar indicates standard deviation for 5 trials. The background level of non-infected cells was 0.296 ± 0.085. Substantial accumulation of protein was produced in φuL36 infected SMQ-86 cells. Figure 5D is a graph showing one-step growth curves for φul36 on L . lactis SMQ-86 and SMQ-88. The phages were allowed to adsorb to the cells for 5 min. , cells were washed twice to remove non-adsorbed phages and then resuspended in LM17 and incubated at 30°C. Time 15 mm corresponded to the first phage count after resuspension in LM17. There was much more progeny phage released from SMQ-86. DESCRIPTION OF PREFERRED EMBODIMENTS The present invention relates to an isolated DNA encoding a protein designated as AbiE which in a Lactococcus lactis increases resistance to phages by aborting infection of Lactococcus l actis by phages, particularly as contained in Lactococcus lactis SMQ20 deposited as NRRL-B-21443 and as set forth in SEQ ID NO: 1. The present invention also relates to a recombinant plasmid containing DNA encoding a protein designated as AbiE which in a Lactococcus l actis increases resistance to phages by aborting infection of Lactococcus lactis by phages, particularly containing the DNA set forth previously. The present invention also relates to a bacterium harboring a recombinant plasmid containing DNA encoding a protein designated as AbiE which in a Lactococcus lactis increases resistance to phages by aborting infection of Lactococcus lactis by phages, particularly a bacterium harboring DNA as set forth previously. The bacterium are preferably Lactococcus, Lactobacillus, Leuconostocs, Pediococcus, Streptococcus thermophilus , Enterococcus, and Bifidobacterium . The present invention further relates to a method of imparting phage resistance to a bacterium which is phage sensitive which comprises transferring DNA encoding a protein designated as AbiE which increases resistance to phages by aborting infection of Lactococcus lactis by phages into the bacterium to impart the phage resistance. Further the present invention relates to a method for fermenting a dairy product, the improvement which comprises using a culture of Lactococcus lactis for the fermenting containing transferred DNA encoding a protein designated as AbiE which increases resistance to phages by aborting infection of Lactococcus lactis by phages to impart the phage resistance and to produce the dairy product. Most particularly the present invention relates to Lactococcus lactis naturally lacking in phage resistance and containing transferred DNA encoding a protein designated as AbiE which increases resistance to phages by aborting infection of Lactococcus l actis by phages, wherein the DNA has a sequence essentially as set forth in SEQ ID NO:l to impart phage resistance to the Lactococcus lactis . The natural plasmid pSRQ800 was isolated from Lactococcus lactis subsp. lactis WI. When introduced into a phage-sensitive . lactis strain, pSRQδOO conferred strong phage resistance against small isometric phages of the 936 and P335 species. It had very limited effect on prolate phages of the c2 species. The phage resistance mechanism encoded on pSRQ800 is a temperature-sensitive abortive infection mechanism (Abi) . Plasmid pSRQ800 was mapped and the Abi genetic determinant localized. Cloning and sequencing of the Abi system allowed the identification of a single open reading frame. This ORF coded for a predicted protein of 599 amino acids with an estimated molecular weight of 71.4 kDa and a pi of 8.0. No significant DNA or protein homology was observed with databases. This novel phage resistance mechanism was named AbiE. No phage replication or production of phage major capsid proteins were detected in infected AbiE + L . lactis cells. This system is believed to act at or prior to phage DNA replication. When cloned into a high copy vector, AbiE became effective against the c2 species. Thus when delivered in an appropriate vector, AbiE system was efficient against the three most commonly found lactococcal phage species. The plasmid pSRQ800 is contained in a deposit of Lactococcus lactis SMQ-20 deposited under the Budapest Treaty with the Northern Regional Research Laboratory in Peoria, Illinois on May 17, 1995 as NRRL- B-21443. DNA plasmid pSRQ700 encoding a restriction or modification system (LlaDCHI) is deposited under the Budapest Treaty as NRRL-B-21337 on September 29, 1994 and is used with pSRQSOO to produce a synergistic result. This DNA is described in U.S. application Serial No. 08/366,480, filed December 30, 1994, which is incorporated by reference herein. The DNA sequence is deposited with GenBank (V16027) . EXAMPLE 1 Materials and Methods Bacterial strains, plasmids, and media. Strains and plasmids used in this application are listed in Tables 1 and 2. Escheri chia col i was grown at 37'C in LB broth. Lactococcus lactis strains were grown at 30'C in M17 (Terzaghi, B. E. , et al., Appl. Environ. Microbiol. 29:807-813 (1975)) supplemented with 0.5% glucose (GM17) or 0.5% lactose (LM17) . When appropriate, antibiotics were added as follows: for E . coli , 50 μg of ampicillin per ml, 10 μg of tetracycline per ml, and 20 μg of chloramphenicol per ml; for L . lactis , 5 μg of chlora phenicol per ml, and 5 μg of erythromycin per ml. Bacteriophage propagation and assays. Bacteriophages used in this study are listed in Table 1. Table 1. Bacterial Strains and Bacteriophages used. Bacterial strains Relevant characteristics'Source 6 or and phages Lactococcus lactis LM0230 Plasmid free, host for 936 and c2 phagesj UL8 Multiple plasmids, host for P335 phages; WI Multiple plasmids including pSRQ800; Lac SMQ-16 LM0230 (ρSA3); Lac- Em' SMQ-20 LM0230 (pSA3, pSRQ800); Lac Em' Abi * SMQ-37 LM0230 (pSRQ801); Lac " Em' SMQ-38 LM0230 (pSRQ802); Lac ' Em' Abi + SMQ-39 LM0230 (pSRQ701); Lac ' Em' R + /M + SMQ-52 LM0230 (pSRQ804); Lac' Em' This invention SMQ-54 LM0230 (pSRQ806); Lac ' Em' This invention SMQ-57 LM0230 (pSRQ809); Lac Em' This invention SMQ-86 UL8 (pSA3); Lac + Em' This invention SMQ-88 UL8 (pSRQ802); Lac + Em' Abi + This invention SMQ-130 LM0230 (pSRQ813); Lac Cm' A i * This invention SMQ-138 LM0230 (pSRQ701, pSRQ813); Lac Em' Cm' R * /M * Abi* This invention SMQ-143 LM0230 (pSRQ815); Lac- Cm' Abi * This invention SMQ-251 LM0230 (pMIG3); Lac " Cm' This invention SMQ-252 LM0230 (pNZ123); Lac Cm' This invention Escherichia coli DH5α Transformation hostGibco/BRL SMQ-92 DH5α (pSRQβlO); Ap' This invention SMQ-116 DH5σ (pSRQ812); Ap' This invention SMQ-129 DH5α (pSRQ814); Ap' This invention Bacteriophages φp2 Small isometric headed, 936 species, 30.5 kbL.L. McKay øskl Small isometric headed, 936 species, 28.1 kbL.L. McKay φjj50 Small isometric headed, 936 species, 30.5 kb φc2 Prolate headed, c2 species, 20.7 kb φml3 Prolate headed, c2 species, 20.2 kbW.E. Sandine φebl Prolate headed. c2 species, 19.6 kbL.L. McKay ul36 Small isometric headed, P335 species, 28.8 kb ΦQ30 Small isometric headed, P335 species, 37.0 kb ΦQ33 Small isometric headed, P335 Bpecies, 29.6 kb Table 1, Footnotes a Abi*, active abortive infection mechanism; Ap, ampicillin resistance; Cm', chloramphenicol resistanc Em', erythromycin resistance; Lac, lactose-fermenting ability; R*/M + , active restriction/modification enzymes; b L.L. McKay, University of Minnesota, Minneapolis; W.E. Sandine, Oregon State University, Corvallis; Table 2. Plasmids used in this invention. Plasmid Relevant characteristics Source ing vector for sequencing, Ap', 2.9-kb Stratagene ie vector. Cm', 5.5-kb ie vector, Cm', 2.5-kb ie vector, Cm' Tc' Em', 10.2-kb b EcoRI fragment from pSRQ700 cloned into pSA3; Cm' Tc' Em' R*/M* ent plasmid of WI, Abi*, 8.0-kb This invention b EcoRI fragment from pSRQ800 cloned into pSA3; Cm' Tc' Em' This invention kb EcoRI fragment from pSRQΘOO cloned into pSA3; Cm' Tc' Em' This invention kb Ncol fragment from pSRQΘOO cloned into ρSA3; Cm' Tc' Em' This invention kb NcoI-EcoRI fragment from pSRQ800 cloned into pSA3; Cm' Tc' Em' This invention kb EcoRV fragment from pSRQ800 cloned into pSA3; Cm' Tc" Em' This invention kb EcoRV-EcoRI from pSRQ800 cloned into pBS; Ap' This invention b EcoRV-Scal from pSRQ802 cloned into pBS; Ap r This invention b fragment from pSRQSOO cloned into pMIG3; Cm' This invention b EcoRI-Scal from pSRQ802 cloned into pBS; Ap' This invention I b EcoRI fragment from pSRQ802 cloned into ρNZ123; Cm' This invention Abi ; , active abortive infection mechanism; Ap', ampicillin resistance; Cm', chloramphenicol resistance; Cm', sensitive to chloramphenicol; Em', erythromycin resistance; Tc', tetracycline resistance; Tc', sensitive to tetracycline; R * /M*, active restriction/ modification enzymes. Bacteriophages c2, p2, ski, and jj50 were a gift from T.R. Klaenham er (North Carolina State University) . All phages were isolated from a single plaque with a 1-ml sterile pipette (Moineau, S., et al., Appl. Environ. Microbiol. 60:1832-1841 (1994)) . They were transferred to GM17 containing lOmM CaCl 2 previously inoculated (1%) with an overnight culture of the host strain. They were incubated at 30'C until lysis and filtered through a 0.45μm filter (Acrodics, Gelman Sciences, Ann Arbor, MI) . High phage titers were then obtained by the method of Jarvis (Jarvis, A. W. , Appl. Environ. Microbiol. 36:785-789 (1978)) . Efficiency of plaquing (EOP) and adsorption assays were performed as described by Sanders and Klaenhammer (Sanders, M. E. , et al., Appl. Environ. Microbiol. 40:500-506 (1980)) . Cell survival was assayed by the method of Behnke and Malke (Behnke, D., et al., Virology, 85:118-128 (1978)) using a MOI of 3. One-step growth curves, center of infection (COI) assays, burst size and latent period determination were performed as described previously (Moineau, S., et al., Appl. Environ. Microbiol. 59:208-212 (1993)). The efficiency at which COI formed (ECOI) was obtained by dividing the number of COI from the resistant strain by the number of COI from the sensitive strain. The intracellular replication of φul36 DNA was also followed at time intervals after phage infection using the Hill et al. procedure (Hill, C. , et al., Appl. Environ. Microbiol. 57:283-288 (1991)) . The production of φul36 major capsid protein (MCP) was followed at time intervals after phage infection using monoclonal antibodies and a sandwich enzyme-linked immunosorbent assay (ELISA) as described previously (Moineau, S., et al., Appl. Environ. Microbiol. 59:2034-2040 (1993) ; and Moineau, S., et al., Appl. Environ. Microbiol. 59:208- 212 (1993) ) . DNA isolation and manipulation. Plasmid DNA from E . col i was isolated as described previously (Moineau, S. , et al., Appl. Environ. Microbiol. 60:1832-1841 (1994)) . Large quantities of E . coli plasmid DNA were isolated with the QIAGEN (Chatsworth, Calif.) plasmid MIDI or MAXI kit. Plasmid DNA from L . lactis was isolated using the method of 0'Sullivan and Klaenhammer (0 1 Sullivan, D. J. , et al., Appl. Environ. Microbiol. 59:2730-2733 (1993)) . Large quantities of lactococcal plasmid DNA were obtained as described by Gonzalez and Kunka (Gonzalez, C. F. , et al., Appl. Environ. Microbiol. 46:81-89 (1983)). Restriction endonucleases (Gibco/BRL, Grand Island, N.Y.) and T4 DNA ligase (Boehringer Mannheim, Indianapolis, Ind.) were used as described by the manufacturer's instructions. Electroporation. E. coli was electroporated as previously described (Moineau, S., et al., Appl. Environ. Microbiol. 60:1832-1841 (1994)). L . lactis was grown in GM17 supplemented with 0.5M sucrose and 1% glycine and electroporated according to the Holo and Nes procedure (Holo, H. , et al., Appl. Environ. Microbiol. 55:3119-3123 (1989)) as modified previously (Moineau, S. , et al., Appl. Environ. Microbiol. 60:1832-1841 (1994) ) . Sequencing. The entire aJbi gene (4.5-kb EcoRI fragment from pSRQ800) could not be cloned in E . coli pBluescript KS+. The 4.5-kb insert was segmented into 3 small fragments (Fig. 3) , subcloned into pBS and transformed into E. coli DH5α with blue and white color selection using IPTG ( i sopropy 1 - β -D- thiogalactopyranoside) and X-Gal (5-bromo-4-chloro-3- indoly-β-D-galactopyranoside) . The resulting clones were named pSRQδlO, pSRQ812 and pSRQ814 (Fig. 3) . Nested deletions were made in both orientation from pSRQ810, pSRQ812 and pSRQ814 with an ERASE-A-BAΞE kit (Pro ega, Madison, Wis.) . Plasmid DNA was extracted from the nested clones with QIAGEN and used directly for sequencing. The sequencing reactions were performed with the DYEDE0XY TERMINATOR TAQ sequencing kit for use on the model 373A automated DNA sequencing system (Applied Biosystems, Foster City, Calif.) . The T7 and T3 primers were used for annealing. DNA and protein analysis. The DNA sequence was analyzed with the Genetics Computer Group (Madison, Wis.) sequence analysis software. The GenBank (release 90, 15 August 95) and ΞwissProt (release 31.0, March 95) databases were searched for homology with the deduced abiE gene and protein. Nucleotide sequence accession number. The complete sequence of 4,467 bp was deposited in the GenBank database and is available under the accession number U35629. Results Isolation of pSRQ800. The objective of this study was to identify phage resistance mechanism(s) present in Lactococcus lactis subsp. lactis WI. The total plasmid DNA of WI was co-electroporated with the shuttle vector pSA3 into the laboratory strain L . lactis LM0230 which is phage-sensitive and plasmid-free. LM0230 was used because of its sensitivity to phages of the 936 and c2 species. The Wl/pSA3 DNA ratio used for electroporation was 10:1. Erythromycin-resistant colonies were obtained (due to pSA3) and tested for phage resistance by spot assay (10 4 φp2/spot) . Some phage-resistant transfor ants were obtained, analyzed and found to contain pSA3 and a 8.0-kb plasmid which was named pSRQ800 (Fig. 1) . One phage-resistant transformant was selected and named . lactis SMQ-20. Effectiveness of pSRQΘOO on three lactococcal phage species. L . lactis SMQ-20 was tested for resistance against three small isometric-headed phages of the 936 species as well as three prolate-headed phages of the c2 species (Table 1) . These 6 phages were individually tested on SMQ-20 and their EOPs are presented in Table 3. EOPs ranging from 10" 6 to 10 "7 were obtained for the 936-type phages φp2 , φskl and øjj50 whereas EOPs of 10' were obtained with prolate øc2 , φml3 and φebl (Table 3). TABLE 3 EOPs of lactococcal phages at 30°C on Lactococcus lactis strains harboring pSRQSOO. a The EOP of the 936 and c2 phages was tested on L . lactis SMQ-20. The EOP of these phages is 1.0 on L. lactis LM0230. b The EOP of the P335 phages was tested on L . lactis SMQ-88. The EOP of these phages is 1.0 on L. lactis SMQ-86. The activity of pSRQδOO was also tested against P335 phages. Since LM0230 cannot replicate P335 phages, pSRQδOO was introduced into an appropriate host. L . lactis ULδ was electroporated with pSRQ802, a derivative of pSRQδOO (see below) , and the transformant named SMQ-88. The EOPs of three P335 phages (øul36, øQ30 and 0Q33) on SMQ-88 are presented in Table 3. The EOPs were variable ranging from 10 "5 to 10 ~8 . These results showed that the phage resistance mechanism encoded on pSRQ800 was effective against small isometric phages of the 936 and P335 species. However, pSRQδOO had very limited effect on prolate phages (c2 species) . Effect of temperature on pSRQSOO. The effect of temperature on the activity of pSRQδOO was tested using øp2. Similar EOPs were obtained at 21°C and at 30'C. However, the EOP of øp2 increased from 4.6 x 10"* to 6.7 x 10" 2 at 38 'C indicating that the phage resistance mechanism encoded on pSRQδOO is heat-sensitive. identification of the phage resistance mechanism on pSRQΘOO. The type of phage defense mechanism located on pSRQ800 was examined. Adsorption experiments indicated that phages adsorbed to the same level (approximately between 90 to 95%) on the phage- sensitive L . lactis LM0230 and on the phage-resistant L . lactis SMQ-20, ruling out the adsorption blocking mechanism. To determine if the mechanism was a R/M system, L . lactis SMQ-20 was challenged with high concentration of øp2. Phages capable of overcoming the pSRQδOO defense system and forming plaques on SMQ-20 were isolated. When these phages were tested back on SMQ-20, we observed that some phages were still inhibited by pSRQδOO while others were unaffected. These former phages were still untouched by pSRQ800 even after propagation on the sensitive host LM0230, indicating a permanent modification. These mutants or øp2 derivatives are under investigation. Nevertheless, these results ruled out the presence of host-controlled modifications such as R/M systems. Based on the current classification of lactococcal phage resistance mechanisms, this system was considered an abortive infection mechanism. Furthermore when challenged with phages, L. lactis SMQ- 20 exhibited the typical Abi + phenotype of reduced plaque size. Localization of the abi gene on pSRQSOO. The plasmid pSRQβOO was mapped using single, double and triple endonuclease digestions. The results are presented in Fig. 2. The following endonucleases did not cut pSRQδOO: Apal, Aval , Bal l , BamHl , Hpa l , Nrul , Pstl , Sai l , Seal , Smal , Sphl , Sstl , Xbal , Xhol . Since appropriate restriction sites were present on pSA3 and pSRQδOO, total plasmid DNA from L . lactis SMQ-20 was digested with EcoRI, EcoRV and/or Ncol, and religated. The ligation mixture was directly electroporated in E . coli DH5α. After obtaining the appropriate clones, plasmid DNA was electroporated into L. lactis LM0230. The Em r transformants were tested for phage resistance. The relevant clones are presented in Fig. 3. Most of the clones (pSRQ801, pSRQ804, pSRQ806, pSRQ809) conferred no resistance (EOP of 1.0) against øp2 (Fig. 3) . Only the clone pSRQ802 gave phage resistance similar to pSRQ800 (EOP of 10^, Fig. 3) . Thus, the full Abi + phenotype was localized on a 4.5-kb EcoRI fragment. DNA and protein sequence analysis of the Abi system. The 4.5-kb fragment containing the Abi + phenotype was sequenced in both directions and found to contain 4,467bp (Fig. 4) . This fragment had a G+C content of 29.5%. Two significant open reading frames (ORFs) were found on the 4.5-kb fragment. The first ORF was localized in one direction from position 1279 to 3075. The second ORF was localized in the other direction from position 4345 to 3491. The clones pSRQ804 and pSRQδ09 which contained the full ORF2 but a disrupted ORF1 exhibited no resistance (EOP of 1.0) against øp2 (Fig. 3) . We concluded that only ORF1 had all the necessary information to confer the Abi + phenotype. The complete ajbi gene contained 1,797 bp with a very low GC content of 23.9%. A putative ribosome binding site (AAAGGAG) was found 8 bases preceding the aJbi gene start codon (Fig. 4) . Putative promoter regions -10 (TATAAT) , 16 bp spacer and -35 (AGCACA) , were found upstream of the aJbi gene (Fig. 4) . No region of dyad symmetry was found at the end of the ajbi gene suggesting the presence of a rho-dependent terminator. No significant DNA homology was found between this abi gene and the GenBank database including the previous sequenced L. lactis abi genes. This novel system was named AbiE. The predicted AbiE protein contained 599 amino acids with an estimated weight of 71,416 Da and a pi of 8.0. No homology to the AbiE protein was found in the SwissProt database, confirming the novelty of AbiE. No transmembrane helix or secretory signals were found indicating that the AbiE protein is most likely intracellular. The Abi + phenotype was totally abolished with the clone pSRQ809 where the last 42 amino acids were missing from the AbiE protein. This result indicated that the C-terminal of the AbiE protein was critical to the Abi + phenotype. Enhancement of AbiE efficiency. The copy number of pSRQδOO was not determined but was estimated to be roughly the same as the low copy vector pSA3 (Fig. 1). The AbiE system was cloned into the high copy plasmid pNZ123 to determine the effect of gene copy number on the AbiE + phenotype. Previously, it was estimated that pSA3 was present in 5 to 10 copies (Dinsmore, P. K. , et al., Appl. Environ. Microbiol. 60:1129-1136 (1994)) whereas pNZ123 was found between 50 to 100 copies in L. lactis (DeVos, W. M. , FEMS Microbiol. Rev. 46:281-295 (1987)). The resulting high copy clone and transformant were named pSRQδlδ and SMQ-143, respectively. The EOP of øp2 on SMQ-143 was 10 "8 which is 2 negative logs higher than the EOP on SMQ-20 which contained the natural plasmid pSRQ800. Interestingly, the EOP of prolate phage c2 was also significantly decreased on SMQ-143. An EOP of 10"* was observed with pSRQ815 whereas EOPs of 10 " ' were observed with pSRQSOO and pSRQ802 (Table 4) . TABLE 4 EOP of øp2 and øc2 on Lactococcus lactis strains harboring various phage resistance mechanisms. These results indicated that multiple copies of abiE gene increase phage resistance against small isometric and prolate phages. EXAMPLE 2 Another way of increasing the efficiency of Abi system is to supply in trans an another phage resistance mechanism (Sing, W. D., et al., Appl. Environ. Microbiol. 59:365-372 (1993)). Previously, we have isolated a L. lactis R/M system named LlaDCHI (formerly Llall) , that was encoded on the plasmid pSRQ700 (Moineau, S., et al., Appl. Environ. Microbiol. 61:2193-2202 (1995)). This plasmid was isolated from the industrial strain L . lactis subsp. cremoris DCH-4. The LlaDCHI genes were previously cloned into pSA3 and the E 'clone named pSRQ701 (Moineau, Ξ., et al., Appl. Environ. Microbiol. 61:2193-2202 (1995)) . Phage p2 had an EOP of 10-* on L. lactis LM0230 harboring pSRQ701 (SMQ-39, Table 4). This phage had also an EOP of lO-* on L. lactis LM0230 harboring pSRQ800 (SMQ-20, Table 4). The abiE gene was cloned into the vector pMIG3 (which contains a Cm r gene) and the clone was named pSRQ813. The EOP of øp2 on LM0230 containing pSRQ813 was slightly lower (10 5 ) (SMQ-130, Table 4) . Plasmids pSRQ701 and pSRQ813 were electroporated into L . lactis LM0230 and the resulting Em'/Cm r transfor ant was named SMQ-138. The EOP of øp2 on SMQ-138 was <10 "9 indicating a full phage resistance phenotype. The EOP of the P335 phage ul36 was also <10 "9 on another L. lactis strain harboring both plasmids (data not shown) . These results showed that AbiE and LlaDCHI R/M system, when supplied in trans , can complement each other to enhance phage resistance levels. Intracellular effects of AbiE system on the phage life cycle. The effects of the AbiE system was tested on the phage ul36 life cycle using the phage-sensitive L. lactis SMQ-86 (pSA3) and phage-resistant L. lactis SMQ- 88 (pSRQ802) . Phage u!36 was selected because it was previously used to characterize two other Abi systems, AbiA and AbiC (Moineau, S., et al., Appl. Environ. Microbiol. 59:20δ-212 (1993)) . The replication of øul36 was severely inhibited on SMQ-8δ as seen by the EOP of 10 " * (Table 5 and Fig. 5C) . Plaques were reduced in size from 1mm to pinpoint and difficult to enumerate (data not shown) . The average number of surviving cells following phage infection (MOI of 3) was 0.06% on SMQ- 86 and 2.65% on SMQ-88 (Table 5) . TABLE 5 Specific effects of AbiE on the lactococcal phage ul36. a Average of five trials. b Average of ten trials. AbiE improved cell survival by approximately 50 fold but still a majority of infected cells died. The ECOI for øul36 on SMQ-88 was 0.0051 indicating that only 5 out of 1000 infected cells successfully release viable phages (Table 5) . The burst size of these productive infections was also reduced from an average of 504 phages on the phage-sensitive SMQ-86 to 36 phages on SMQ-88 (Table 5) . Furthermore, the phage latent period was longer on SMQ-68 by approximately 15 min. (Figure 5C) . These results indicated that øul36 took more time to complete its life cycle on an AbiE + host and that the number of released phages was reduced by almost 15 fold. The cumulative effects of AbiE on the cell survival, ECOI, burst size and latent period were responsible for the severely reduced EOP of øul36 on SMQ-8δ (Table 5) . The intracellular replication of øul36 DNA was followed on SMQ-δ6 and SMQ-8δ (Fig. 5A and 5B) . No replication of øul36 could be detected in L. lactis SMQ-δδ whereas significant replication occurred in SMQ- 86. The intracellular production of øul36 major capsid protein was also followed on SMQ-δ6 and SMQ-88 (Fig. 5C) . The MCP is the most abundant structural protein of øul36 (Moineau, S., et al., Appl. Environ. Microbiol. 59:2034-2040 (1993)) . Using an ELISA detection system, barely no MCP protein was detected in infected SMQ-88 cells (O.D. = 0.389) whereas massive amount of MCP was detected in infected SMQ-86 cells (corrected O.D. = 22.618) . These results indicated that AbiE might act at or prior to phage DNA replication. RESULTS As can be seen from Examples 1 and 2 , Lactococcus lactis subsp. lactis strain WI harbors a 8.0-kb plasmid (pΞRQ800) coding for a temperature- sensitive abortive phage infection mechanism. The genetic element responsible for the Abi + phenotype was cloned and sequenced from pSRQ800. One gene was necessary for the Abi + phenotype. AbiE displayed the classical abortive infection phenotype (Molineux, I. J. , New Biol. 3:230- 236 (1991); Sing, W. D., et al., J. Dairy Sci. 73:2239- 2251 (1990); and Snyder, L. , Mol. Microbiol. 15:415-420 (1995)) . The presence of pSRQδOO increased the survival of infected cells by almost 50-fold demonstrating that AbiE was successful in aborting phage infection. Substantial cell death (9δ%) still occurred upon phage abortion (Table 5) suggesting that cell damage was too considerable for recovery. Very few infected AbiE + cells released progeny phages (0.5%) and when these rare productive infections occurred, the latent period was longer (by 15 min) and the ' burst size reduced by 15- fold. The overall effect of AbiE can be visualized as a reduction in number and size of phage plaques. Thus, AbiE acted internally to interfere with the phage lytic development. AbiE encoded on its natural plasmid pSRQδOO, inhibited the development of small isometric phages of the 936 and P335 species but had very limited effect on the prolate c2 species (Table 3) . However if the abiE gene was cloned into the high copy vector pNZ123, a 4 log increase in resistance was noticed against phage øc2. This indicated that AbiE can be efficient against prolate phages when present in high copy number. A 2 log increase was also observed with øp2 (Table 3) . Elevated efficiencies with high copy genes has also been observed with L. lactis AbiA (Casey, J. , et al., Appl. Environ. Microbiol. 58:3283-3291 (1992) ; and Dinsmore, P. K. , et al. , Appl. Environ. Microbiol. 60:1129-1136 (1994)) . Therefore, the natural plasmid pSRQ800 can bestow strong resistance against small isometric phages (936 and P335 species) and if the functional gene is delivered in an appropriate vector, AbiE can be effective against all three common lactococcal phage species (Jarvis, A. W., et al., Intervirology 32:2-9 (1991)) . Five other L. lactis Abi systems have been sequenced (Anba, J. , et al., J. Bacteriol. 177:3818- 3823 (1995) ; Cluzel, P. J. , et al., Appl. Environ. Microbiol. 57:3547-3551 (1991); Durmaz, E. , et al., J. Bacteriol. 174:7463-7469 (1992) ; Hill, C. , et al., Appl. Environ. Microbiol. 56:2255-2258 (1990); and McLandsborough, L. A., et al., Appl. Environ. Microbiol. 61:2023-2026 (1995)). In all cases, only one gene was necessary to confer the Abi + phenotype. The five deduced Abi proteins had 628 (AbiA) , 251 (AbiB) , 344 (AbiC), 366 (AbiD), and 351 (AbiDl) amino acids. Thus, AbiE (599 aa, 71.4-kDa) would be closer to AbiA (628 aa and 73.8 kDa) based on protein size. Functionally, AbiE was also similar to AbiA. This was evidenced by its efficient inhibition of 936 and P335 species (Casey, J., et al., Appl. Environ. Microbiol. 58:3283-3291 (1992); Dinsmore, P. K. , et al., Appl. Environ. Microbiol. 60:1129-1136 (1994); and Hill, C, et al., Appl. Environ. Microbiol. 56:2255- 2258 (1990)), its increased activity against prolate phages with high copy (Casey, J. , et al., Appl. Environ. Microbiol. 58:3283-3291 (1992) ; and Dinsmore, P. K. , et al., Appl. Environ. Microbiol. 60:1129-1136 (1994)) and is heat sensitivity (Hill, C, et al., Appl. Environ. Microbiol. 56:2255-2258 (1990)) . The AbiA phage target is currently unknown but it is believed to act prior to ø DNA replication since no DNA replication and MCP production were observed in infected AbiA + cells (Moineau, S., et al., Appl. Environ. Microbiol. 59:208-212 (1993)) . Similar DNA replication and MCP production results were obtained with AbiE (Figures 5C and 5D) . Even though AbiE shared phenotypic similarities with AbiA, no significant amino acid homology was found between the two proteins. When developing phage-resistant cultures, one approach is to stack different phage resistance mechanisms within one strain (Durmaz, E., et al., Appl. Environ. Microbiol. 61:1266-1273 (1995) ; and Sing, W. D. , et al., Appl. Environ. Microbiol. 59:365-372 (1993)). In fact some natural L. lactis plasmids like pTR2030 (Hill, C. , et al., Appl. Environ. Microbiol. 56:2255-2258 (1990) ; and O'Sullivan, D. J. , et al., J. Bacteriol. 177:134-143 (1995)) and pTN20 (Durmaz, E. , et al., J. Bacteriol. 174:7463-7469 (1992)), already encode two distinct phage resistance mechanisms: an abortive infection mechanism and a R/M system. In these two plasmids, the Abi and R/M systems naturally complement each other to confer very strong phage resistance (EOP <10 "9 ) . AbiE and LlaDCHI are considered strong phage resistance mechanisms since EOPs of 10"* were observed with some phages (Moineau, S., et al., Appl. Environ. Microbiol. 61:2193-2202 (1995), Table 3) . However on their own, both systems are leaky and a high phage population (> 10 6 ) can overpower them. When AbiE and LlaDCHI were introduced in L . lactis strains, a full resistance phenotype (EOP <10" 9 ) was observed against 936 and P335 phages (Table 4) . These results demonstrated the beneficial effect of providing in trans an Abi and a R/M system. Similar added resistance have been previously observed with other in trans L . lactis anti-phage systems (Durmaz, E. , et al., Appl. Environ. Microbiol. 61:1266-1273 (1995) ; and Sing, W. D. , et al., Appl. Environ. Microbiol. 59:365-372 (1993)) . This is believed to be the first instance where such a strong resistance is observed with completely characterized Abi and R/M systems presented in trans in L . lactis . From a practical and current regulatory point of view, the introduction of the natural plasmid pSRQ800 into an industrial L. lactis strain to confer strong resistance against small-isometric phages of the 936 and P335 species, is useful. It is useful against c2 phage species when the AbiE gene is provided in large copy number. The foregoing description is only illustrative of the present invention and the present invention is limited only by the hereinafter appended claims . APPENDIX I (1) GENERAL INFORMATION: (i) Applicant: Sylvain Moineau, Barbara J. Holler, Peter A. Vandenbergh, Ebenezer R. Vedamuthu, Jeffrey K. Kondo (ii) Title of Invention: DNA Encoding Phage Abortive Infection Protein From Lactococcus lactis , and Method of Use Thereof (iii) Number of Sequences: 1 (iv) Correspondence Address: (A) Addressee: Ian C. McLeod (B) Street: 2190 Commons Parkway (C) City: Okemos (D) State: Michigan (E) Country: USA (F) Zip: 48864 (v) Computer Readable Form: (A) Medium Type: Diskette 5.25 inch, 360 Kb storage (B) Computer: Acer (C) Operating System: MS-DOS (version 4) (D) Sof ware: WordPerfect 5.1 (vi) Current Application Data: (A) Application Number: 08/565,907 (B) Filing Date: December 1, 1995 (C) Classification: (vii) Prior Application Data: (A) Application Number: (B) Filing Date: (viii) Attorney/Agent Information: (A) Name: Ian C. McLeod (B) Registration Number: 20,931 (C) Reference/Docket Number: (ix) Telecommunication Information: (A) Telephone: (517) 347-4100 (B) Telefax: (517) 347-4103 (C) Telex: None (2) Information for SEQ ID NO: 1 (i) Sequence Characteristics: (A) Length: 4467 (B) Type: Nucleotide (C) Strandedness : Single (D) Topology: Linear (ii) Molecule Type: (A) Description: Genomic DNA (iii) HYPOTHETICAL: No (iv) ANTI-SENSE: No (v) FRAGMENT TYPE: N/A (vi) ORIGINAL SOURCE: (A) Organism: Lactococcus lactis (B) Strain: (C) Individual Isolate: WI (D) Developmental Stage: N/A (E) Haplotype: N/A (F) Tissue Type: N/A (G) Cell Type: bacterium (H) Cell Line: N/A (I) Organelle: N/A (vii) IMMEDIATE SOURCE: (A) Library: genomic (B) Clone: SMQ-20 (viii) POSITION IN GENOME: N/A (ix) FEATURE: (A) Name/Key: phage abortive infection (B) Location: N/A (C) Identification Method: sequencing (D) Other Information: DNA encoding phage resistance (x) PUBLICATION INFORMATION: N/A (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1 GAATTCATGT TTTGTTGGAT GAGCCATGCA TGATAAAGCA TTAAATCTTG TTGGACAGGT 60 TTTAAATATA ACGTATTTCC CTTACCTGTT TTTTGATCAT GAATAAATGC AGTTTGTTTG 120 ACTGTTCCAT CAAGATTAAA GACATCTGTT TTTTTTAATT TCATGACGTC ACTCACACGT 180 AGCAAGGTCG CTTTCCCAAC TTGGAAAATT GTATAGTTAC GACGACCAGC ACGAAAACTA 240 TCAAGTAGTG TATCCTGCAC CATTTTTAAG ATATTTGAAT CTTTAATCGG TAAAACAAGT 300 TGTTGCACCA TGATACTATT GCTCCTTTAA AATCAATTAA TTGCTTTATG ATAGCAAATA 360 CGCTATCATA ATAGTATGGA AAAATTTGAG TTTGATTATT ACGATTGGGC TGAATTTGAA 420 CAGTTCTTAG ATCAGTTACC TGATAAAGAT GCTGCTAAGT TAATTGCAAC CATTCAAAAT 480 ATTGAAAATA ATGGCCTCTT AGTCGCTGAA AGACAATTAT GGGTCAAAAA ACTAGAAAAT 540 AATCTTTATG AAATTCGTTC TAAGCGAGCT TCAAACATCC AAAGAGCGAT TTATTTTAAA 600 GTCAAAGGTA GTCAATACAT TATTACTAAT GCGTTCACGA AAAAAACGCA AAAGACACCT 660 GAAAATCAAA AGGAAATTGC TCGGAATAGA CGCAGTCAGT ATTTGAATAA GGAGGAAAAC 720 CAATGAGTAA ACTTGATGCA TATGTTGCTG AACGTAGTAA AAAAAATCCC AAATTTTCAC 780 AAATTGTTGA GCAAGAAAAT ATTAATTTAG AGGTGGCAGT AAAAGTCCAT GACCTGCGTG 840 AAAATATGGG GTTAAGTCAA CGTGAATTTG CTACTCTGAT TGGTAAACCA CAATCAACCA 900 TCGCACGCAT TGAAAATGGT TCGATGAATG CTTCAACAAA AATGTTATCA GAGATTGCCC 960 AAGCTACTAA TCAACGATTA ACTATTCAAT TTAATTCTAC ATTTTAAGAT CTATTATATC 1020 ATTTAACAAA AAAATAGCCC CTAATAAACC AAAGTAATTT ATTAGGGGCT ATTTTAATAG 1080 TTTTTTAAAG GGGTTATTTT CTAATTATAG TCCCTTAATT TCCATTTTCG TGTCTAATTA 1140 TTTGACATTA GTCCATACAA TAGTGACTCT AAGATTTAAG GATAACATCA ACTTTCAACA 1200 TAAGCACAAT AACTATTTTT TTATTATAAT TGAAAAGAGA ATTGAATTAT TACCTATAAA 1260 ACTTAAAGGA GTATAATT ATG AAA AAA GAG TTT ACT GAA TTA TAT GAT 1308 Met Lys Kys Glu Phe Thr Glu Leu Tyr Asp 5 10 TTT ATA TTT GAT CCT ATT TTT CTT GTA AGA TAC GGC TAT TAT GAT 1353 Phe lie Phe Asp Pro lie Phe Leu Val Arg Tyr Gly Tyr Tyr Asp 15 20 25 AGA TCT ATT AAA ACC AAA AAA ATG AAT CCT CCA AAA GTT GAA TTA 1398 Arg Ser lie Lys Thr Lys Lys Met Asn Pro Pro Lys Val Glu Leu 30 35 40 GAC AAT GAA TAT GGA AAA TCA GAT TCT TTT TAT TTT AAA GTA TTT 1443 Asp Asn Glu Tyr Gly Lys Ser Asp Ser Phe Tyr Phe Lys Val Phe 45 50 55 AAT ATG GAA TCC TTT GCA GAT TAT TTA AGG AGT CAT GAT TTA AAA 1488 Asn Met Glu Ser Phe Als Asp Tyr Leu Arg Ser His Asp Leu Lys 60 65 70 ACA CAT TTT AAC GGT AAA AAA CCT CTA TCA ACA GAC CCA GTA TAT 1533 Thr His Phe Asn Gly Lys Lys Pro Leu Ser Thr Asp Pro Val Tyr 75 80 85 TTT AAT ATT CCA AAA AAT ATA GAA GCT AGA AGA CAA TAT AAG ATG 1578 Phe Asn lie Pro Lys Asn lie Glu Ala Arg Arg Gin Tyr Lys Met 90 95 100 CCC AAT TTA TAC AGT TAT ATG GCA TTA AAT TAT TAT ATA TGT GAC 1623 Pro Asn Leu Tyr Ser Tyr Met Ala Leu Asn Tyr Tyr lie Cys Asp 105 110 115 AAT AAA AAA GAG TTT ATA GAA GTA TTT ATT GAT AAC AAA TTT TCA 1668 Asn Lys Lys Glu Phe lie Glu Via Phe lie Asp Asn Lys Phe Ser 120 125 130 ACG TCA AAA TTT TTT AAT CAA TTG AAT TTT GAT TAT CCT AAG ACA 1713 Thr Ser Lys Phe Phe Asn Gin Leu Asn Phe Asp Tyr Pro Lys Thr 135 140 145 CAA GAA ATT ACA CAA ACA TTA TTA TAT GGA GGA ATA AAG AAA TTA 1758 Gin Glu lie Thr Gin Thr Leu Leu Tyr Gly Gly lie Lys Lys Leu 150 155 160 CAT TTA GAT TTA TCT AAT TTT TAT CAT ACT TTA TAT ACA CAT AGT 1803 His Leu Asp Leu Ser Asn Phe Tyr His Thr Leu Tyr Thr His Ser 165 170 175 ATA CCA TGG ATG ATT GAT GGA AAA TCT GCA TCT AAA CAA AAT AGA 1848 lie Pro Trp Met lie Asp Gly Lys Ser Ala Ser Lys Gin Asn Arg 180 185 190 AAA AAA GGG TTT TCT AAT ACA TTA GAT ACT TTG ATT ACA GCT TGT 1893 Lys Lys Gly Phe Ser Asn Thr Leu Asp Thr Leu lie Thr Ala Cys 1938 1983 2028 2073 2118 2163 2208 2253 2298 2343 2388 2433 2478 2523 2568 2613 2658 2703 2748 2793 2838 2883 525 530 535 AAA GAG ATA AAT AGT TAT TGT CAA TCT CAA AAC TAT AAT TCA GGA 2928 Lys Glu He Asn Ser Tyr Cys Gin Ser Gin Asn Tyr Asn Ser Gly 540 545 550 CAG AAC GGA TAT CAA ACA GAA CTT AAT TGG AAT TAT ATT AAA GGT 2973 Gin Asn Gly Tyr Gin Thr Glu Leu Asn Trp Asn Tyr He Lys Gly 555 560 565 CAA GGG AAG GAT CTT AGA GCG AAT AAC TTT TTT AAT GAA TTG ATA 3018 Gin Gly Lys Asp Leu Arg Ala Asn Asn Phe Phe Asn Glu Leu He 570 575 580 GTA AAA GAA GTT TGG TTA ATT TCT TGT GGT GAG AAC GAA GAT TTC 3063 Val Lys Glu Val Trp Leu He Ser Cys Gly Glu Asn Glu Asp Phe 585 590 595 AAA TAT TTA AAT TGA TA AGTATTTGAA ATCTATTATT AGTTCCTGAA AAAATAGCTG 3120 Lys Tyr Leu Asn TGTCTTGTCA ATATAAATGA CAAGACACAG CTATTTTTTT TAATTTTGAA ATTTATAATT 31B0 TTAAATGAAC ATTTTTTGTA AGAAACCTTT TTTCTGTTCT TTCAATAAAT CTAATTTCCG 3240 CTGATGAAGA GCGATAGTGT CATCTAGCTG TTTAAAGAAT GAACCTATTT TTTGTTGCTC 3300 TGAATTATTC TGAGGAATCG ATAGCTTCAG TTCAGTCAAC ATGTCCATAA CAATGTACGG 3360 AATATTTCCT GTACGAGCTT CCTGTTTTAT TTTTTTAGGC AGCTTATTTC CAATTTCTGA 3420 AAATATAAAA CTTCTATCTA CTAGAAACTC TTGGAGCACA TAAGTTCGTT GATAGGCATT 3480 GAACTTATTA TCCGGCTAAA TGCATGTATC CAACTGTTGC TCCATTACCT GCAATTGTAA 3540 TGGACGGTCC TTCAAACGCT GCTACATCGA TCCTATATTT TTTAATTCCA GAAGTATAAA 3600 AATCATACTT GCCATTTTCA ACCATTGCAT TTGCATCTAA TTTTCCGGTG CTTATTTTAG 3660 TAATATCTCC TAACTTACGC TCTTCCCAAT CGTCAGCAAA CCCCGCAAAT CGCAATTCAG 3720 GAACTTTAGC CCCATTTTTA GGGAACATTT TTTGTAAGAA GCCTTTTTTC TGTTCCTTGA 3780 GCAAATCTAA CTTACGCTGA TGAAGAGCGA TAGTGTTATC CAGCTGCTTG AAGAATGAAC 3840 CGATTTTGTC TTGTTCCTCA ATTGCAGGGA CACTTATTAT AGCTTCTTTA ATATCAGTAG 3900 AATTAATACT TTCAAATGTT GATCCAGTGC TATATCTAGT CCAATACCCG TCGGACTTCA 3960 TTTTACCAAG ATTTTGAAAT ATAAATTCAT TACCTTTTAT GGCAGCAACA CCTCGACCAA 4020 TAACAACGTC ATAAGCTGTT TTACCAATAT CTCCAACCGG TGCTCGGACA CTTAGAATGA 4080 GATCATCTTT TTCAGCTTGT TTAGTAACTT GAGTTGTCCA TACTCTCGGT AAAACACGAC 4140 CATTTTTCAT GTCAGCATTA CCTTGCACAA GAATATAATC ATTAGGATCA TCAGTATAAT 4200 TTTCTGAATT AGGAGACTGT CCCATCACTA TTCGAACTTC GTCTCCCAAC TTACGCAGTT 4260 CCCATTCATC CGTGAATCCT TTAAATCGCA ATTCTGGAAC TTTCTTTTTA ACTGAATCAT 4320 CTATTTTCGC CATAGTCCCC ACCATTTTCT TGGTTTTTCT TGTTCTTCTA TCCTTTTTTG 4380 ATCTTTGATT TGTTCCTGCA AATTTTCCAA CTTCTCTTTA AGAGCGTTCA CTTCATCTTT 4440 ATATTGATTG TCTAAGTGTT TGAATTC 4467

Claims: WE CLAIM: -1- An isolated DNA encoding a protein designated as AbiE which in a Lactococcus lactis increases resistance to phages by aborting infection of the Lactococcus lactis by phages. -2- An isolated DNA encoding a protein designated as AbiE including comprising in plasmid pSRQSOO as contained in Lactococcus lactis SMQ-20 deposited as NRRL-B-21443. -3- The DNA of Claim 2 which is in a 4.5 kb EcoRI segment contained in plasmid pSRQ800. -4- An isolated DNA having a nucleotide sequence essentially as set forth in SEQ ID NO:l. -5- A recombinant plasmid containing DNA encoding a protein designated as AbiE which in a Lactococcus lactis increases resistance to phages by aborting infection of the Lactococcus lactis by the phages. -6- The plasmid of Claim 5 which is a shuttle vector pSA3 containing the DNA. ■ 7- The plasmid of Claim 5 which is pNZ123 containing the DNA. -8- The plasmid of Claim 5 wherein the DNA is in plasmid pSRQδOO contained in Lactococcus lactis pSMQ-20 deposited as NRRL-B-21443. -9- A recombinant plasmid containing DNA having a nucleotide sequence as set forth in SEQ ID NO:l which encodes a protein designated as AbiE. -10- The plasmid of Claim 9 which is a shuttle vector pSA3 containing the DNA. -11- The plasmid of Claim 9 which is PNZ123 containing the DNA. -12- A bacterium harboring a recombinant plasmid containing DNA encoding a protein designated as AbiE which in a Lactococcus lactis increases resistance to phage by aborting infection of the Lactococcus lactis by the phages. -13- The bacteria of Claim 12 which is a lactic acid producing bacteria selected from the group consisting of Lactococcus, Lactobacillus , Leuconostocs, Pediococcuε, Streptococcus tbermophilus , Enterococcus and Bifodobacterium . -14- The bacterium of Claim 12 which is Eεcherichia coli . -15- The bacterium of Claim 12 which is a Lactococcus lactis . -16- The bacterium of Claim 12 harboring a shuttle vector pSA3 containing the DNA. -17- The bacterium of Claim 12 harboring pNZ123 containing the DNA. -18- The bacterium of Claim 12 wherein the DNA is contained in plasmid pSRQβOO contained in a Lactococcus lactis pSMQ-20 deposited as NRRL-B-21443. -19- A bacterium containing DNA having a nucleotide sequence as set forth in SEQ ID NO 1 which encodes a protein designated as AbiE which increases abortion of infection by phages. -20- The bacterium of Claim 19 harboring a shuttle vector pSA3 containing the DNA. -21- The bacterium of Claim 19 harboring PNZ123 containing the DNA. -22- A method of imparting phage resistance to a bacterium which is sensitive to the phage which comprises transferring DNA encoding a protein designated as AbiE which increases resistance to phages by aborting infection of Lactococcus lactis by the phages into the bacterium to impart the phage resistance. -23- The method of Claim 22 wherein the DNA encoding the member is contained in strain Lactococcus lactis SMQ-20 deposited as NRRL-B-21443. -24- The method of Claim 22 wherein the DNA transferred in a shuttle vector pSA3. -25- The method of Claim 22 wherein the DNA transferred is in pNZ123. -26- A method of Claim 22 wherein a recombinant plasmid containing the DNA which has a nucleotide sequence as set forth in SEQ ID NO:l which encodes the protein designated as ABiE is transferred. -27- A method of Claim 26 wherein in the DNA transferred is in a shuttle vector pSA3. -28- A method of Claim 26 wherein the DNA transferred is in pNZ123. -29- The method of Claim 22 wherein the bacterium is a Lactococcus lactis . -30- The method of Claim 22 wherein the DNA transferred is selected from the group consisting of plasmid DNA. -31- The method of Claim 22 wherein the DNA transferred is in a vector for transforming the bacterium. -32- In a method for fermenting a dairy product, the improvement which comprises using a culture of Lactococcus lactis for the fermenting containing transferred DNA encoding a protein designated as AbiE which increases resistance to phages by aborting infection of Lactococcus lactis by the phages to impart the phage resistance and to produce the dairy product. -33- The method of Claim 32 wherein the DNA is contained in strain Lactococcus lactis SMQ-20 deposited as NRRL-B-21443. -34- The method of Claim 32 wherein the DNA is in a plasmid. -35- The method of Claim 32 wherein the DNA is in a vector which was used to transfer the DNA by transformation, selected from the group consisting of plasmid DNA. -36- The method of Claim 32 wherein the DNA is in a shuttle vector pSA3. -37- The method of Claim 32 wherein the DNA is in pNZ123. -38- The method of Claim 32 wherein the DNA is in recombinant plasmid containing DNA having a nucleotide sequence as set forth in SEQ ID NO 1 which encodes the protein designated as AbiE. -39- The method of Claim 38 wherein the DNA is in a shuttle vector pSA3 containing the DNA. -40- The method of Claim 38 wherein the DNA is in pNZ123 containing the DNA. -41- The method of Claim 32 wherein the DNA is in a natural plasmid deposited as pSRQ800. -42- The method of Claim 32 wherein in addition the culture contains DNA encoding a restriction or modification system which imparts phage resistance. -43- The method of Claim 42 wherein the DNA is contained is Lactococcus lactis NRRL-B-21337. -44- Lactococcus lactis naturally lacking in phage resistance and containing transferred DNA encoding a protein designated as AbiE which increases resistance to phages by aborting infection of Lactococcus lactis by the phages, wherein the DNA has a sequence essentially as set forth in SEQ ID NO:l to impart phage resistance to the Lactococcus lactis . -45- The Lactococcus lactis of Claim 44 wherein the DNA is contained in Lactococcus lactis SMQ-20 deposited as NRRL-B-21443. -46- The Lactococcus lactis of Claim 44 wherein the DNA is in a plasmid. -47- The Lactococcus lactis of Claim 44 wherein the DNA is in a vector for transformation. -48- A portein designated as AbiE having an amino acid sequence essentially as set forth in SEQ ID NO:l. -49- A protein designated as AbiE having at least 75% identity with the amino acid sequence as set forth in SEQ ID NO:l.

Inventors: HOLLER BARBARA J, KONDO JEFFREY K, MOINEAU SYLVAIN, VANDENBERGH PETER A, VEDAMUTHU EBENEZER R, HOLLER, BARBARA, J., KONDO, JEFFREY, K., MOINEAU, SYLVAIN, VANDENBERGH, PETER, A., VEDAMUTHU, EBENEZER, R.
Applicants: HOLLER BARBARA J, KONDO JEFFREY K, MOINEAU SYLVAIN, QUEST INT, VANDENBERGH PETER A, VEDAMUTHU EBENEZER R, HOLLER, BARBARA, J., KONDO, JEFFREY, K., MOINEAU, SYLVAIN, QUEST INTERNATIONAL B.V., VANDENBERGH, PETER, A., VEDAMUTHU, EBENEZER, R.
Application year: 1996
Main classification: C12N
IPC codes: A23C19, C07K14, C12N1, C12N15